China's medical device maker Zylox-Tonbridge shines in Hong Kong debut
Reuters2021-07-05
** Shares of China's medical device manufacturer Zylox-Tonbridge Medical Technology Co Ltd trade as high as HK$58.75 in their Hong Kong debut, up 37.6% from the IPO price of HK$42.70 apiece
** Stock is third most actively traded by turnover
** The Zhejiang-based maker of medical devices for treatment of neuro and peripheral vascular diseases offered 60 mln H shares in its Hong Kong IPO, raising HK$2.56 bln ($329.6 mln) for R&D, production, commercialization of core products
** The Hong Kong Hang Seng Commerce & Industry Index slips 0.8%, while the healthcare index gains 0.1%
** The Hang Seng China Enterprises Index slides 0.7%, and the benchmark index edges down 0.1%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
